; . 304. Grant program on harms of drug misuse Part D of title V of the Public Health Service Act ( 42 U.S.C. 290dd et seq. ), as amended by section 301, is further amended by adding at the end the following: 554. Grant program on harms of drug misuse (a) In general The Assistant Secretary, in consultation with the Director of the Centers for Disease Control and Prevention, shall award grants to States and political subdivisions of States to support the delivery of overdose prevention services, including distribution of Food and Drug Administration-approved opioid reversal agents such as naloxone, fentanyl strips, and other harm reduction services that address the harms of drug misuse, including by— (1) connecting individuals at risk for, or with, a substance use disorder to overdose education, counseling, and health education; and (2) encouraging such individuals to take steps to reduce the harms associated with substance misuse. (b) Considerations In awarding grants under this section, the Assistant Secretary shall prioritize grants to applicants that are— (1) organizations providing culturally competent care in terms of considerations based on race, language, ethnicity, gender, sexuality, or disability; or (2) proposing to serve areas with— (A) a higher proportion of the population who meet criteria for dependence on, or abuse of, illicit drugs; (B) a higher drug overdose death rate; and (C) a greater behavioral health and substance use disorder workforce need. (c) Special considerations A recipient of a grant under this section for the purposes described in subsection (a)(2) shall provide overdose prevention services, as follows: (1) Ensure that not less than 60 percent of the grant funds are used for harm reduction programs. (2) Prioritize the delivery of opioid antagonists to— (A) people who use opioids or illicit drugs; (B) families of such people; (C) first responders such as law enforcement personnel and nonemergency services such as fire fighters and park rangers